1887

Chapter 2 : Staphylococcal and Streptococcal Superantigens: an Update

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Staphylococcal and Streptococcal Superantigens: an Update, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815844/9781555814243_Chap02-1.gif /docserver/preview/fulltext/10.1128/9781555815844/9781555814243_Chap02-2.gif

Abstract:

This chapter provides an introduction to bacterial superantigen (SAg) and presents the current understanding of disease association and causation by SAgs, with the intent of identifying needed future research studies of SAgs. Bacterial SAgs include those produced by β-hemolytic streptococci (including ), and , , and certain species of . In the chapter the authors consider only T-cell SAgs; definitions listed may be easily adapted to define B-cell SAgs. The pyrogenic toxin SAgs include the staphylococcal enterotoxins (SEs), which are known to cause emesis when administered orally to monkeys, and thus are the causes of staphylococcal food poisoning. Streptococcal pyrogenic exotoxins (SPEs) (erythrogenic toxins, scarlet fever toxins) now include the classic SPEs A and C, but also serotypes G, H, I, J, K, L, M, streptococcal superantigen (SSA), and streptococcal mitogenic exotoxin Z (SMEZ). The last aspect of the author's presentation of new horizons for SAg research is based on the premise that human diseases caused by SAgs begin with their interaction with epithelial cells. Both group A streptococci and cause infections that begin on skin and mucous membranes and, most of these organisms make SAgs. Clearly, additional studies are necessary to clarify all aspects of the interaction with mucosal and skin surfaces. These studies are likely to more fully define the extent of SAg involvement in human illnesses, and at the same time characterize the mechanism of SAg penetration of these surfaces.

Citation: Schlievert P, Bohach G. 2007. Staphylococcal and Streptococcal Superantigens: an Update, p 21-36. In Kotb M, Fraser J (ed), Superantigens. ASM Press, Washington, DC. doi: 10.1128/9781555815844.ch2

Key Concept Ranking

Immune Systems
0.5580243
Major Histocompatibility Complex Class II
0.4422079
Amino Acids
0.42423734
Toxic Shock Syndrome
0.40904233
Viruses
0.40495455
0.5580243
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815844.ch02
1. Abali, O.,, H. Nazik,, K. Gurkan,, E. Unuvar,, M. Sidal,, B. Ongen,, F. Oguz, and, U. Tuzun. 2006. Group A beta hemolytic streptococcal infections and obsessive-compulsive symptoms in a Turkish pediatric population. Psychiatry Clin. Neurosci. 60:103105.
2. Acharya, K. R.,, E. F. Passalacqua,, E. Y. Jones,, K. Harlos,, D. I. Stuart,, R. D. Brehm, and, H. S. Tranter. 1994. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 367:9497.
3. Alber, G.,, D. K. Hammer, and, B. Fleischer. 1990. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J. Immunol. 144:45014506.
4. Alber, G.,, P. H. Scheuber,, B. Reck,, B. Sailer-Kramer,, A. Hartmann, and, D. K. Hammer. 1989. Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys. J. Allergy Clin. Immunol. 84: 880885.
5. Anonymous. 1993. CDC defines group A streptococcal toxic shock syndrome. Am. Fam. Physician 47:16431644.
6. Anonymous. 1999. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus–Minnesota and North Dakota, 1997–1999. JAMA 282:11231125.
7. Anonymous. 2003. Methicillin-resistant Staphylococcus aureus infections in correctional facilities– Georgia, California, and Texas, 2001–2003. Morb. Mortal. Wkly. Rep. 52:992996.
8. Arad, G.,, D. Hillman,, R. Levy, and, R. Kaempfer. 2004. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide. Immunol. Lett. 91:141145.
9. Arad, G.,, D. Hillman,, R. Levy, and, R. Kaempfer. 2001. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock. J. Leukoc. Biol. 69:921927.
10. Arad, G.,, R. Levy,, D. Hillman, and, R. Kaempfer. 2000. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med. 6:414421.
11. Assimacopoulos, A. P.,, J. A. Stoehr, and, P. M. Schlievert. 1997. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome. Adv. Exp. Med. Biol. 418:109114.
12. Baker, B. S.,, S. Bokth,, A. Powles,, J. J. Garioch,, H. Lewis,, H. Valdimarsson, and, L. Fry. 1993. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br. J. Dermatol. 128:493499.
13. Bergdoll, M. S. 1988. Monkey feeding test for staphylococcal enterotoxin. Methods Enzymol. 165:324333.
14. Bergdoll, M. S.,, B. A. Crass,, R. F. Reiser,, R. N. Robbins, and, J. P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1:10171021.
15. Bernstein, J. M.,, M. Ballow,, P. M. Schlievert,, G. Rich,, C. Allen, and, D. Dryja. 2003. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am. J. Rhinol. 17:321326.
16. Blomster-Hautamaa, D. A.,, B. N. Kreiswirth,, J. S. Kornblum,, R. P. Novick, and, P. M. Schlievert. 1986. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J. Biol. Chem. 261:1578315786.
17. Bohach, G. A.,, D. J. Fast,, R. D. Nelson, and, P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17:251272.
18. Choi, Y.,, J. A. Lafferty,, J. R. Clements,, J. K. Todd,, E. W. Gelfand,, J. Kappler,, P. Marrack, and, B. L. Kotzin. 1990. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172:981984.
19. Cole, B. C. 1991. The immunobiology of Mycoplasma arthritidis and its superantigen MAM. Curr. Top. Microbiol. Immunol. 174:107119.
20. Cole, B. C., and, C. L. Atkin. 1991. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol. Today 12:271276.
21. Cone, L. A.,, D. R. Woodard,, R. G. Byrd,, K. Schulz,, S. M. Kopp, and, P. M. Schlievert. 1992. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J. Infect. Dis. 165:638643.
22. Cone, L. A.,, D. R. Woodard,, P. M. Schlievert, and, G. S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317:146149.
23. Dale, R. C. 2005. Post-streptococcal autoimmune disorders of the central nervous system. Dev. Med. Child Neurol. 47:785791.
24. Dale, R. C.,, I. Heyman,, G. Giovannoni, and, A. W. Church. 2005. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br. J. Psychiatry 187:314319.
25. Daum, R. S.,, T. Ito,, K. Hiramatsu,, F. Hussain,, K. Mongkolrattanothai,, M. Jamklang, and, S. Boyle-Vavra. 2002. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylo-coccus aureus isolates of diverse genetic backgrounds. J. Infect. Dis. 186:13441347.
26. Davis, C. C.,, M. J. Kremer,, P. M. Schlievert, and, C. A. Squier. 2003. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189:17851791.
27. Davis, J. P.,, P. J. Chesney,, P. J. Wand, and, M. LaVenture. 1980. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303:14291435.
28. Dinges, M. M.,, J. Jessurun, and, P. M. Schlievert. 1998. Comparisons of mouse and rabbit models of toxic shock syndrome. Int. Congr. Symp. Ser. 229:167168.
29. Dinges, M. M., and, P. M. Schlievert. 2001. Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect. Immun. 69:71697172.
30. England, R. J.,, D. R. Strachan, and, L. C. Knight. 1997. Streptococcal tonsillitis and its association with psoriasis: a review. Clin. Otolaryngol. Allied Sci. 22:532535.
31. Giantonio, B. J.,, R. K. Alpaugh,, J. Schultz,, C. McAleer,, D. W. Newton,, B. Shannon,, Y. Guedez,, M. Kotb,, L. Vitek,, R. Persson,, P. O. Gunnarsson,, T. Kalland,, M. Dohlsten,, B. Persson, and, L. M. Weiner. 1997. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J. Clin. Oncol. 15:19942007.
32. Hamad, A. R.,, P. Marrack, and, J. W. Kappler. 1997. Transcytosis of staphylococcal superantigen toxins. J. Exp. Med. 185:14471454.
33. Harris, T. O.,, D. Grossman,, J. W. Kappler,, P. Marrack,, R. R. Rich, and, M. J. Betley. 1993. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect. Immun. 61:31753183.
34. Hasegawa, T.,, K. Torii,, S. Hashikawa,, Y. Iinuma, and, M. Ohta. 2002. Cloning and characterization of two novel DNases from Streptococcus pyogenes. Arch. Microbiol. 177:451456.
35. Herz, U.,, R. Ruckert,, K. Wollenhaupt,, T. Tschernig,, U. Neuhaus-Steinmetz,, R. Pabst, and, H. Renz. 1999. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness–a model for non-allergic asthma. Eur. J. Immunol. 29:10211031.
36. Hirooka, E. Y.,, E. E. Muller,, J. C. Freitas,, E. Vicente,, Y. Yoshimoto, and, M. S. Bergdoll. 1988. Entero-toxigenicity of Staphylococcus intermedius of canine origin. Int. J. Food Microbiol. 7:185191.
37. Hofer, M. F.,, R. J. Harbeck,, P. M. Schlievert, and, D. Y. Leung. 1999. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J. Invest. Dermatol. 112:171176.
38. Hofer, M. F.,, M. R. Lester,, P. M. Schlievert, and, D. Y. Leung. 1995. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin. Exp. Allergy 25:12181227.
39. Hovde, C. J.,, J. C. Marr,, M. L. Hoffmann,, S. P. Hackett,, Y. I. Chi,, K. K. Crum,, D. L. Stevens,, C. V. Stauffacher, and, G. A. Bohach. 1994. Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. Mol. Microbiol. 13:897909.
40. Igwe, E. I.,, P. L. Shewmaker,, R. R. Facklam,, M. M. Farley,, C. van Beneden, and, B. Beall. 2003. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol. Lett. 229:259264.
41. Iwasaki, M.,, H. Igarashi,, Y. Hinuma, and, T. Yutsudo. 1993. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett. 331: 187192.
42. Jablonski, L. M., and, G. A. Bohach. 2001. Staphylococcus aureus, p. 410434. In M. D. L. Beuchat and, T. Montville (ed.), Fundamental of Food Microbiology. ASM Press, Washington, D.C.
43. Jackow C. M.,, J. C. Cather,, V. Hearne,, A. T. Asano,, J. M. Musser, and, M. Duvic. 1997. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood 89:3240. (Erratum, 89:3496.)
44. Kent, T. H. 1966. Staphylococcal enterotoxin gastroenteritis in rhesus monkeys. Am. J. Pathol. 48:387407.
45. Kim, J.,, R. G. Urban,, J. L. Strominger, and, D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:18701874.
46. Kim, S. W.,, J. E. Grant,, S. I. Kim,, T. A. Swanson,, G. A. Bernstein,, W. B. Jaszcz,, K. A. Williams, and, P. M. Schlievert. 2004. A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosci. 16:252260.
47. Komisar, J.,, J. Rivera,, A. Vega, and, J. Tseng. 1992. Effects of staphylococcal enterotoxin B on rodent mast cells. Infect. Immun. 60:29692975.
48. J. Tseng., Kotb, M.,, A. Norrby-Teglund,, A. McGeer,, H. El-Sherbini,, M. T. Dorak,, A. Khurshid,, K. Green,, J. Peeples,, J. Wade,, G. Thomson,, B. Schwartz, and, D. E. Low. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:13981404.
49. Kotzin, B. L.,, D. Y. Leung,, J. Kappler, and, P. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99166.
50. Kravitz, G.,, D. J. Dries,, M. L. Peterson, and, P. M. Schlievert. 2005. Purpura fulminans due to Staphylo-coccus aureus. Clin. Infect. Dis. 40: 941947.
51. Kuroda, M.,, T. Ohta,, I. Uchiyama,, T. Baba,, H. Yuzawa,, I. Kobayashi,, L. Cui,, A. Oguchi,, K. Aoki,, Y. Nagai,, J. Lian,, T. Ito,, M. Kanamori,, H. Matsumaru,, A. Maruyama,, H. Murakami,, A. Hosoyama,, Y. Mizutani-Ui,, N. K. Takahashi,, T. Sawano,, R. Inoue,, C. Kaito,, K. Sekimizu,, H. Hirakawa,, S. Kuhara,, S. Goto,, J. Yabuzaki,, M. Kanehisa,, A. Yamashita,, K. Oshima,, K. Furuya,, C. Yoshino,, T. Shiba,, M. Hattori,, N. Ogasawara,, H. Hayashi, and, K. Hiramatsu. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:12251240.
52. Kushnaryov, V. M.,, M. S. Bergdoll,, H. S. MacDonald,, J. Vellinga, and, R. Reiser. 1984. Study of staphylococcal toxic shock syndrome toxin in human epithelial cell culture. J. Infect. Dis. 150:535545.
53. Kushnaryov, V. M.,, H. S. MacDonald,, R. Reiser, and, M. S. Bergdoll. 1984. Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized. Infect. Immun. 45:566571.
54. Kushnaryov, V. M.,, H. S. MacDonald,, R. F. Reiser, and, M. S. Bergdoll. 1989. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev. Infect. Dis. 11(Suppl. 1):S282S287.
55. Lee, P. K.,, B. N. Kreiswirth,, J. R. Deringer,, S. J. Projan,, W. Eisner,, B. L. Smith,, E. Carlson,, R. P. Novick, and, P. M. Schlievert. 1992. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J. Infect. Dis. 165:10561063.
56. Lee, P. K.,, G. M. Vercellotti,, J. R. Deringer, and, P. M. Schlievert. 1991. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J. Infect. Dis. 164:711719.
57. Leung, D. Y.,, H. C. Meissner,, D. R. Fulton,, D. L. Murray,, B. L. Kotzin, and, P. M. Schlievert. 1993. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342: 13851388.
58. Leung, D. Y.,, H. C. Meissner,, S. T. Shulman,, W. H. Mason,, M. A. Gerber,, M. P. Glode,, B. L. Myones,, J. G. Wheeler,, R. Ruthazer, and, P. M. Schlievert. 2002. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J. Pediatr. 140:742746.
59. Leung, D. Y.,, J. B. Travers,, R. Giorno,, D. A. Norris,, R. Skinner,, J. Aelion,, L. V. Kazemi,, M. H. Kim,, A. E. Trumble,, M. Kotb,et al. 1995. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J. Clin. Invest. 96: 21062112.
60. Li, H.,, A. Llera,, D. Tsuchiya,, L. Leder,, X. Ysern,, P. M. Schlievert,, K. Karjalainen, and, R. A. Mariuzza. 1998. Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity 9:807816.
61. Lina, G.,, G. A. Bohach,, S. P. Nair,, K. Hiramatsu,, E. Jouvin-Marche, and, R. Mariuzza. 2004. Standard nomenclature for the superantigens expressed by Staphylococcus. J. Infect. Dis. 189:23342336.
62. Lindsay, J. 1996. Infectious agents and sudden infant death syndrome (SIDS): an update. Mol. Med. Today 2:9495.
63. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520532.
64. MacDonald, K. L.,, M. T. Osterholm,, C. W. Hedberg,, C. G. Schrock,, G. F. Peterson,, J. M. Jentzen,, S. A. Leonard, and, P. M. Schlievert. 1987. Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA 257:10531058.
65. Malchiodi, E. L.,, E. Eisenstein,, B. A. Fields,, D. H. Ohlendorf,, P. M. Schlievert,, K. Karjalainen, and, R. A. Mariuzza. 1995. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J. Exp. Med. 182:18331845.
66. Manders, S. M.,, W. R. Heymann,, E. Atillasoy,, J. Kleeman, and, P. M. Schlievert. 1996. Recurrent toxin-mediated perineal erythema. Arch. Dermatol. 132:5760.
67. Marrack, P., and, J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705711.
68. Marrack, P.,, E. Kushnir, and, J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349:524526.
69. McCormick, J. K., and, P. M. Schlievert. 2006. Toxins and superantigens of group A streptococci, p. 4758. In V. A. Fischetti,, R. P. Novick,, J. J. Ferretti,, D. A. Portnoy, and, J. I. Rood (ed.), Gram-Positive Pathogens. American Society for Microbiology, Washington, D.C.
70. McCormick, J. K.,, T. J. Tripp,, A. S. Llera,, E. J. Sundberg,, M. M. Dinges,, R. A. Mariuzza, and, P. M. Schlievert. 2003. Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes. J. Immunol. 171:13851392.
71. McCormick, J. K.,, J. M. Yarwood, and, P. M. Schlievert. 2001. Toxic shock syndrome and bacterial super-antigens: an update. Annu. Rev. Microbiol. 55:77104.
72. Mitchell, D. T.,, D. G. Levitt,, P. M. Schlievert, and, D. H. Ohlendorf. 2000. Structural evidence for the evolution of pyrogenic toxin superantigens. J. Mol. Evol. 51:520531.
73. Newbould, M. J.,, J. Malam,, J. M. McIllmurray,, J. A. Morris,, D. R. Telford, and, A. J. Barson. 1989. Immunohistological localisation of staphylococcal toxic shock syndrome toxin (TSST-1) antigen in sudden infant death syndrome. J. Clin. Pathol. 42:935939.
74. Norrby-Teglund, A.,, D. Newton,, M. Kotb,, S. E. Holm, and, M. Norgren. 1994. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect. Immun. 62:52275233.
75. Novick, R. P. 2000. Pathogenicity factors and their regulation., p. 392407. In R. P. Novick,, V. A. Fischetti,, J. J. Ferretti,, D. A. Portnoy, and, J. I. Rood (ed.), Gram-Positive Pathogens. ASM Press, Washington, D.C.
76. Orwin, P. M.,, J. R. Fitzgerald,, D. Y. Leung,, J. A. Gutierrez,, G. A. Bohach, and, P. M. Schlievert. 2003. Characterization of Staphylococcus aureus enterotoxin L. Infect. Immun. 71:29162919.
77. Orwin, P. M.,, D. Y. Leung,, H. L. Donahue,, R. P. Novick, and, P. M. Schlievert. 2001. Biochemical and biological properties of staphylococcal enterotoxin K. Infect. Immun. 69:360366.
78. Orwin, P. M.,, D. Y. Leung,, T. J. Tripp,, G. A. Bohach,, C. A. Earhart,, D. H. Ohlendorf, and, P. M. Schlievert. 2002. Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry 41:1403314040.
79. Osterholm, M. T.,, J. P. Davis,, R. W. Gibson,, J. S. Mandel,, L. A. Wintermeyer,, C. M. Helms,, J. C. Forfang,, J. Rondeau, and, J. M. Vergeront. 1982. Tri-state toxic-state syndrome study. I. Epidemiologic findings. J. Infect. Dis. 145:431440.
80. Parsonnet, J., M., A. Hansmann,, M. L. Delaney,, P. A. Modern,, A. M. Dubois,, W. Wieland-Alter,, K. W. Wissemann,, J. E. Wild,, M. B. Jones,, J. L. Seymour, and, A. B. Onderdonk. 2005. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 43:46284634.
81. Patrizi, A.,, A. M. Costa,, L. Fiorillo, and, I. Neri. 1994. Perianal streptococcal dermatitis associated with gut-tate psoriasis and/or balanoposthitis: a study of five cases. Pediatr. Dermatol. 11:168171.
82. Peterson, M.,, K. Ault,, M. J. Kremer,, A. J. Klingelhutz,, C. C. Davis,, C. A. Squier, and, Schlievert, P. M. 2005. Innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin-1. Infect. Immun. 73:21642174.
83. Prasad, G. S.,, C. A. Earhart,, D. L. Murray,, R. P. Novick,, P. M. Schlievert, and, D. H. Ohlendorf. 1993. Structure of toxic shock syndrome toxin 1. Biochemistry 32:1376113766.
84. Proft, T.,, P. D. Webb,, V. Handley, and, J. D. Fraser. 2003. Two novel superantigens found in both group A and group C Streptococcus. Infect. Immun. 71:13611369.
85. Reingold, A. L.,, N. T. Hargrett,, B. B. Dan,, K. N. Shands,, B. Y. Strickland, and, C. V. Broome. 1982. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann. Intern. Med. 96:871874.
86. Sachse, S.,, P. Seidel,, D. Gerlach,, E. Gunther,, J. Rodel,, E. Straube, and, K. H. Schmidt. 2002. Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp. equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). FEMS Immunol. Med. Microbiol. 34: 159167.
87. Scherer, M. T.,, L. Ignatowicz,, G. M. Winslow,, J. W. Kappler, and, P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9:101128.
88. Schiffenbauer, J.,, H. M. Johnson,, E. J. Butfiloski,, L. Wegrzyn, and, J. M. Soos. 1993. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 90:85438546.
89. Schiffenbauer, J.,, J. Soos, and, H. Johnson. 1998. The possible role of bacterial superantigens in the patho-genesis of autoimmune disorders. Immunol. Today 19:117120.
90. Schlievert, P. M. 1986. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1:11491150.
91. Schlievert, P. M.,, K. M. Bettin, and, D. W. Watson. 1978. Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock. Proc. Soc. Exp. Biol. Med. 157:472475.
92. Schlievert, P. M.,, K. M. Bettin, and, D. W. Watson. 1979. Production of pyrogenic exotoxin by groups of streptococci: association with group A. J. Infect. Dis. 140:676681.
93. Schlievert, P. M.,, K. M. Bettin, and, D. W. Watson. 1979. Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect. Immun. 26:467472.
94. Schlievert, P. M., and, D. A. Blomster. 1983. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147:236242.
95. Schlievert, P. M.,, L. M. Jablonski,, M. Roggiani,, I. Sadler,, S. Callantine,, D. T. Mitchell,, D. H. Ohlen-dorf, and, G. A. Bohach. 2000. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect. Immun. 68:36303634.
96. Schlievert, P. M.,, M. Y. Kotb, and, D. L. Stevens. 2000. Streptococcal superantigens: streptococcal toxic shock syndrome. In M. W. Cunningham and, R. S. Fujinami (ed.), Effects of Microbes on the Immune System. Lippincott Williams & Wilkins, Philadelphia, Pa.
97. Schlievert, P. M.,, M. T. Osterholm,, J. A. Kelly, and, R. D. Nishimura. 1982. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann. Intern. Med. 96:937940.
98. Schlievert, P. M.,, K. N. Shands,, B. B. Dan,, G. P. Schmid, and, R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143:509516.
99. Schlievert, P. M.,, T. J. Tripp, and, M. L. Peterson. 2004. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000–2003 surveillance period. J. Clin. Microbiol. 42:28752876.
100. Schlievert, P. M., and, D. W. Watson. 1979. Biogenic amine involvement in pyrogenicity and enhancement of lethal endotoxin shock by group A streptococcal pyrogenic exotoxin. Proc. Soc. Exp. Biol. Med. 162:269274.
101. Schlievert, P. M., and, D. W. Watson. 1978. Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infect. Immun. 21:753763.
102. Shands, K. N.,, G. P. Schmid,, B. B. Dan,, D. Blum,, R. J. Guidotti,, N. T. Hargrett,, R. L. Anderson,, D. L. Hill,, C. V. Broome,, J. D. Band, and, D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303:14361442.
103. Shupp, J. W.,, M. Jett, and, C. H. Pontzer. 2002. Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect. Immun. 70:21782186.
104. Smoot, L. M.,, J. K. McCormick,, J. C. Smoot,, N. P. Hoe,, I. Strickland,, R. L. Cole,, K. D. Barbian,, C. A. Earhart,, D. H. Ohlendorf,, L. G. Veasy,, H. R. Hill,, D. Y. Leung,, P. M. Schlievert, and, J. M. Musser. 2002. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect. Immun. 70: 70957104.
105. Sriskandan, S.,, M. Unnikrishnan,, T. Krausz, and, J. Cohen. 2000. Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes. Microbiology 146(Pt 11):27852792.
106. Stevens, D. L.,, M. H. Tanner,, J. Winship,, R. Swarts,, K. M. Ries,, P. M. Schlievert, and, E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:17.
107. Stuart, P. M.,, R. K. Munn,, E. DeMoll, and, J. G. Woodward. 1995. Characterization of human T-cell responses to Yersinia enterocolitica superantigen. Hum. Immunol. 43:269275.
108. Sugiyama, H., and, T. Hayama. 1965. Abdominal viscera as site of emetic action from staphylococcal enterotoxin in the monkey. J. Infect. Dis. 115:330336.
109. Sundberg, E. J.,, H. Li,, A. S. Llera,, J. K. McCormick,, J. Tormo,, P. M. Schlievert,, K. Karjalainen, and, R. A. Mariuzza. 2002. Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure 10:687699.
110. Swedo, S. E., and, P. J. Grant. 2005. Annotation: PANDAS: a model for human autoimmune disease. J. Child Psychol. Psychiatry 46:227234.
111. Todd, J. K.,, F. A. Kapral,, M. Fishaut, and, T. R. Welch. 1978. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 2:11161118.
112. Tomai, M. A.,, P. M. Schlievert, and, M. Kotb. 1992. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect. Immun. 60:701705.
113. Toyosaki, T.,, T. Yoshioka,, Y. Tsuruta,, T. Yutsudo,, M. Iwasaki, and, R. Suzuki. 1996. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C. Eur. J. Immunol. 26: 26932701.
114. Uchiyama, T.,, T. Miyoshi-Akiyama,, H. Kato,, W. Fujimaki,, K. Imanishi, and, X. J. Yan. 1993. Super-antigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol. 151:44074413.
115. Vath, G. M.,, C. A. Earhart,, J. V. Rago,, M. H. Kim,, G. A. Bohach,, P. M. Schlievert, and, D. H. Ohlen-dorf. 1997. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 36:15591566.
116. Yutsudo, T.,, H. Murai,, J. Gonzalez,, T. Takao,, Y. Shimonishi,, Y. Takeda,, H. Igarashi, and, Y. Hinuma. 1992. A new type of mitogenic factor produced by Streptococcus pyogenes. FEBS Lett. 308: 3034.

Tables

Generic image for table
Table 1.

Clinical definition of toxic shock syndrome

Citation: Schlievert P, Bohach G. 2007. Staphylococcal and Streptococcal Superantigens: an Update, p 21-36. In Kotb M, Fraser J (ed), Superantigens. ASM Press, Washington, DC. doi: 10.1128/9781555815844.ch2
Generic image for table
Table 2.

Defining properties of T-cell SAgs

Citation: Schlievert P, Bohach G. 2007. Staphylococcal and Streptococcal Superantigens: an Update, p 21-36. In Kotb M, Fraser J (ed), Superantigens. ASM Press, Washington, DC. doi: 10.1128/9781555815844.ch2
Generic image for table
Table 3.

Categorization of pyrogenic toxin SAgs

Citation: Schlievert P, Bohach G. 2007. Staphylococcal and Streptococcal Superantigens: an Update, p 21-36. In Kotb M, Fraser J (ed), Superantigens. ASM Press, Washington, DC. doi: 10.1128/9781555815844.ch2
Generic image for table
Table 4.

Human disease causation/association with SAgs

Citation: Schlievert P, Bohach G. 2007. Staphylococcal and Streptococcal Superantigens: an Update, p 21-36. In Kotb M, Fraser J (ed), Superantigens. ASM Press, Washington, DC. doi: 10.1128/9781555815844.ch2

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error